MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT) and Boston Scientific, today announced settlements in two cases and an agreement to stand down in three other lawsuits. These agreements stop all current litigation between the two parties in the fields of interventional cardiology and endovascular repair. All the disputes were over intellectual property.
